Defense Logistics Agency (DLA) Request for Information (RFI): Country of Origin and API Source Disclosure for Generic Pharmaceutical Products
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Logistics Agency (DLA) is issuing a Request for Information (RFI) to gather industry data on Country of Origin and API Source Disclosure for Generic Pharmaceutical Products. This RFI supports market research for proposed legislation aimed at enhancing supply chain transparency. Responses are requested by April 9, 2026.
Scope of Work
DLA seeks detailed information on:
- Manufacturing origin of finished generic pharmaceutical products.
- Country of origin for each Active Pharmaceutical Ingredient (API) and its relative weight percentage.
- Current packaging disclosure capabilities and feasible methods for adding country of origin and API source information.
- Industry feedback on the feasibility, willingness, and potential operational, regulatory, supply chain, or cost impacts of implementing proposed labeling requirements.
Contract & Timeline
- Type: Special Notice / Request for Information (RFI)
- Purpose: Market research and planning only; not a solicitation.
- Set-Aside: None specified.
- Response Due: April 9, 2026, 7:00 PM ET
- Published: March 30, 2026
Additional Notes
This RFI is for information and planning purposes only and does not constitute a commitment by the Government. Respondents are encouraged to use a product-level table or matrix and clearly identify any proprietary or business-sensitive information. Submissions should include company name, CAGE code, point of contact, and email address.